Mazher Ahmed Mohammed
The possible utilization of radionuclides in treatment has been perceived for a long time. Various radionuclides, for example, iodine-131 (131I), phosphorous-32 (32P), strontium-90 (90Sr), and yttrium-90 (90Y), have been utilized effectively for the treatment of numerous benevolent and harmful issues. As of late, the fast development of this part of atomic medication has been animated by the presentation of various new radionuclides and radiopharmaceuticals for the treatment of metastatic bone torment and neuroendocrine and other dangerous or non-threatening tumors. Today, the field of radionuclide treatment is appreciating an energizing stage and is ready for more prominent development and advancement in the coming years.
இந்தக் கட்டுரையைப் பகிரவும்